169
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Barriers and Solutions to Improve Therapeutic Adherence from the Perspective of Primary Care and Hospital-Based Physicians

, ORCID Icon, ORCID Icon, , , ORCID Icon & show all
Pages 697-707 | Published online: 11 Mar 2022

References

  • Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2(6):757–764. doi:10.1161/01.HYP.2.6.757
  • Laufs U, Rettig-Ewen V, Böhm M. Strategies to improve drug adherence. Eur Heart J. 2011;32(3):264–268. doi:10.1093/eurheartj/ehq297
  • World Health Organization. Adherence to long-term therapies: evidence for action. Washington D.C.: World Health Organization; 2003. Available from: https://www.who.int/chp/knowledge/publications/adherence_report/en/. Accessed February 24, 2021.
  • Jin J, Sklar GE, Min Sen Oh V, Chuen LS. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269–286. doi:10.2147/TCRM.S1458
  • Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011.
  • Conn VS, Ruppar TM, Chase JD. Blood pressure outcomes of medication adherence interventions: systematic review and meta-analysis. J Behav Med. 2016;39(6):1065‐1075. doi:10.1007/s10865-016-9730-1
  • Rodríguez Chamorro MA, García Jiménez E, Amariles P, Rodríguez Chamorro A, Faus MJ. Revisión de tests de medición del cumplimiento terapéutico utilizados en la práctica clínica. [Review of the measurement tests for therapeutic compliance used in clinical practice]. Aten Primaria. 2008;40(8):413–417. doi:10.1157/13125407
  • Márquez Contreras E, Gil Guillén V, Casado Martínez JJ, et al. Analysis of studies published on hypertension treatment non-compliance in Spain between 1984 and 2005. Aten Primaria. 2006;38(6):325–332. doi:10.1157/13093369
  • Seng JJB, Tan JY, Yeam CT, Htay H, Foo WYM. Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature. Int Urol Nephrol. 2020;52(5):903–916. doi:10.1007/s11255-020-02452-8
  • Yeam CT, Chia S, Tan HCC, Kwan YH, Fong W, Seng JJB. A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int. 2018;29(12):2623–2637. doi:10.1007/s00198-018-4759-3
  • Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev Med. 2017;99:269‐276. doi:10.1016/j.ypmed.2017.03.008
  • Rafii F, Fatemi NS, Danielson E, Johansson CM, Modanloo M. Compliance to treatment in patients with chronic illness: a concept exploration. Iran J Nurs Midwifery Res. 2014;19(2):159–167.
  • Shahin W, Stupans I, Kennedy G. Health beliefs and chronic illnesses of refugees: a systematic review. Ethn Health. 2018;11:1–13. doi:10.1080/13557858.2018.1557118
  • Shahin W, Kennedy GA, Stupans I. The impact of personal and cultural beliefs on medication adherence of patients with chronic illnesses: a systematic review. Patient Prefer Adherence. 2019;13:1019‐1035. doi:10.2147/PPA.S212046
  • Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. Br Med J. 2006;333(7557):15. doi:10.1136/bmj.38875.675486.55
  • Hameed MA, Dasgupta I. Medication adherence and treatment-resistant hypertension: a review. Drugs Context. 2019;8:212560. doi:10.7573/dic.212560
  • Miguel VS. Técnicas cualitativas de investigación social. Reflexión metodológica y práctica profesional. [Qualitative techniques of social research. Methodological reflection and professional practice]. 2nd ed. Madrid, Spain: Editorial. Síntesis SA; October, 2000
  • Zaugg V, Korb‐Savoldelli V, Durieux P, Sabatier B. Providing physicians with feedback on medication adherence for people with chronic diseases taking long‐term medication. Cochrane Database Syst Rev. 2018;2018(1). doi:10.1002/14651858.CD012042.pub2
  • Carratalá-Munuera MC, Gil-Guillén VF, Orozco-Beltrán D, et al. Barriers associated with poor control in Spanish diabetic patients. A consensus study. Int J Clin Pract. 2013;67(9):888–894. doi:10.1111/ijcp.12160
  • Ladova K, Vlcek J, Vytrisalova M, Maly J. Healthy adherer effect - the pitfall in the interpretation of the effect of medication adherence on health outcomes. J Eval Clin Pract. 2014;20(2):111–116. doi:10.1111/jep.12095
  • Mahtani KR, Heneghan CJ, Glasziou PP, Perera R. Reminder packaging for improving adherence to self‐administered long‐term medications. Cochrane Database Syst Rev. 2011;9. doi:10.1002/14651858.CD005025.pub3
  • Castellano JM, Sanz G, Peñalvo JL, et al. A polypill strategy to improve adherence: results from the FOCUS project. J Am Coll Cardiol. 2014;64(20):2071–2082. doi:10.1016/j.jacc.2014.08.021
  • National Institute for Health and Clinical Excellence. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. Clinical guideline 76; 28 January 2009. Available from: https://www.nice.org.uk/guidance/cg76. Accessed February 24, 2021.
  • Freixa-Pamias R, Gràcia PB, Rodríguez Latre ML, et al. Impact of an integral assistance model between primary care and cardiology on the management of patients with ischemic heart disease or atrial fibrillation. J Comp Eff Res. 2019;8(2):103‐111. doi:10.2217/cer-2018-0088
  • Mabotuwana T, Warren J, Kennelly J. A computational framework to identify patients with poor adherence to blood pressure lowering medication. Int J Med Inform. 2009;78(11):745–756. doi:10.1016/j.ijmedinf.2009.06.006
  • Warren J, Kennelly J, Warren D, et al. Using the general practice EMR for improving blood pressure medication adherence. Stud Health Technol Inform. 2012;178:228–234.
  • Carvalho AS, Santos P. medication adherence in patients with arterial hypertension: the relationship with healthcare systems’ organizational factors. Patient Prefer Adherence. 2019;13:1761–1774. doi:10.2147/PPA.S216091
  • Carratala-Munuera C, Gil-Guillen VF, Orozco-Beltran D, et al. Barriers to improved dyslipidemia control: delphi survey of a multidisciplinary panel. Fam Pract. 2015;32(6):672–680. doi:10.1093/fampra/cmv038
  • Ministerio de Sanidad, Servicios Sociales e Igualdad. Estrategia para el abordaje de la cronicidad en el Sistema Nacional de Salud. [Strategy for addressing chronicity in the National Health System]. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2012. Available from: https://www.mscbs.gob.es/organizacion/sns/planCalidadSNS/pdf/ESTRATEGIA_ABORDAJE_CRONICIDAD.pdf. Accessed February 24, 2021.